ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · IEX Real-Time Price · USD
60.74
-1.04 (-1.68%)
Jun 18, 2024, 4:00 PM EDT - Market closed

ANI Pharmaceuticals Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for ANI Pharmaceuticals stock have an average target of 81.33, with a low estimate of 77 and a high estimate of 87. The average target predicts an increase of 33.90% from the current stock price of 60.74.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $77 $81.33 $80 $87
Change +26.77% +33.90% +31.71% +43.23%
* Price targets were last updated on May 13, 2024.

Analyst Ratings

The average analyst rating for ANIP stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '24Feb '24Mar '24Apr '24May '24Jun '24
Strong Buy 333333
Buy 112211
Hold 000000
Sell 000000
Strong Sell 000000
Total 445544

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$83$87
Strong Buy Maintains $83$87 +43.23% May 13, 2024
Guggenheim
Guggenheim
Strong Buy
Reiterates
$77
Strong Buy Reiterates $77 +26.77% Apr 23, 2024
Capital One
Capital One
Buy
Initiates
n/a
Buy Initiates n/a n/a Mar 15, 2024
Guggenheim
Guggenheim
Strong Buy
Maintains
$70$77
Strong Buy Maintains $70$77 +26.77% Mar 5, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$73$83
Strong Buy Maintains $73$83 +36.65% Mar 4, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
553.46M
from 486.82M
Increased by 13.69%
Revenue Next Year
590.20M
from 553.46M
Increased by 6.64%
EPS This Year
4.58
from 0.85
Increased by 438.32%
EPS Next Year
5.09
from 4.58
Increased by 11.19%
Year 2019202020212022202320242025202620272028
Revenue
206.55M208.48M216.14M316.39M486.82M553.46M590.20M625.35M649.73M675.35M
Revenue Growth
2.47%0.93%3.67%46.38%53.87%13.69%6.64%5.96%3.90%3.94%
EPS
0.50-1.88-3.40-3.050.854.585.095.696.126.80
EPS Growth
-61.54%----438.32%11.19%11.92%7.48%11.11%
Forward PE
-----13.2711.9410.679.928.93
No. Analysts -----77655
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 578.3M 615.4M 659.0M 699.0M 738.9M
Avg 553.5M 590.2M 625.4M 649.7M 675.4M
Low 526.8M 554.8M 591.0M 602.5M 609.4M

Revenue Growth

Revenue Growth 20242025202620272028
High
18.8%
11.2%
11.7%
11.8%
13.7%
Avg
13.7%
6.6%
6.0%
3.9%
3.9%
Low
8.2%
0.2%
0.1%
-3.7%
-6.2%

EPS Forecast

EPS 20242025202620272028
High 4.85 5.61 6.31 6.81 7.41
Avg 4.58 5.09 5.69 6.12 6.80
Low 4.21 4.43 5.03 5.24 6.07

EPS Growth

EPS Growth 20242025202620272028
High
470.7%
22.5%
24.0%
19.7%
21.1%
Avg
438.3%
11.2%
11.9%
7.5%
11.1%
Low
395.8%
-3.2%
-1.2%
-7.9%
-0.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.